BioMed X inaugurates its new institute in the USA with a research project on complex ex vivo models of tissue inflammation in collaboration with AbbVie.

After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.

A new technology developed by BioMed X in collaboration with Janssen functionally identifies and validates T cell target antigens, making it a powerful tool for immunology discovery.

BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie.

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.

The Vilcek Foundation has published an audiobook — Dr. Jan Vilcek's 2016 memoir 'Love and Science,' narrated by Daniel K. Isaac

Across Rare Diseases, Neuroscience/Mental Health, Immunology and Gastroenterology

Orion Biotechnology to Announce Novel Potency Data

Nancy Alexander, Account Director, Southeast at Sanofi Genzyme, joins networking organization

New study explains what happens when the immune system ages

Labscoop Welcomes Industry Leading Immunology Antibodies and Ancillary Reagents Manufacturer Tonbo Biosciences. One of the fastest growing life science companies offering high performance, value-oriented products of the highest quality.

The 150,000th article recommendation, published today in F1000Prime (http://f1000.com/prime), identifies an important research article that helps our understanding of how consumption of fish oils could help protect against certain allergies.

The European Academy of Allergy and Clinical Immunology (EAACI) will hold its annual congress 16 - 20 June in Geneva (Switzerland).

Greiner Bio One announces new social networking sites for direct customer interaction. The first 50 customers to email mackenziefarone@gbo.com to tell us they "liked" our facebook page, gets $50 off their next purchase!

International Stem Cell Corporation announced that its oocyte collection and activation protocol has received the approval of an Institutional Review Board, a Federal requirement for all studies enrolling human subjects, and ensures appropriate subj

International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company's development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are

International Stem Cell Corporation, an international pioneer and leader in stem cell research, announced that its wholly owned subsidiary, Lifeline Skin Care Inc., has achieved positive results in human safety tests of its cosmetic products and is m

NewsRx has published a new encyclopedia on vaccines -- Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals.